SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549



                                   FORM 8-K/A

                            CURRENT REPORT PURSUANT
                        TO SECTION 13 OR 15 (D) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of earliest event reported): August 18, 2004

                              ___________________


                     FISHER SCIENTIFIC INTERNATIONAL INC.
            (Exact name of registrant as specified in its charter)


                                   Delaware
                (State or other jurisdiction of incorporation)


            1-10920                                      02-0451017
      (Commission File No.)                   (IRS Employer Identification No.)


   One Liberty Lane, Hampton, New Hampshire                  03842
   (Address of principal executive offices)                (Zip Code)


                                (603) 926-5911
             (Registrant's telephone number, including area code)







                               TABLE OF CONTENTS


ITEM 2. Acquisition or Disposition of Assets

SIGNATURE

Exhibit Index
EX-99.1 Press Release dated August 2, 2004





         This is an amendment to the Form 8-K filed on August 3, 2004 by
Fisher to reflect that the information filed under Item 5 is to be filed
under Item 2:


ITEM 2.  ACQUISITION OR DISPOSITON OF ASSETS.

         On August 2, 2004, the stockholders of Fisher Scientific
International Inc., a Delaware corporation ("Fisher"), approved the issuance
of Fisher common stock, in connection with the merger contemplated by the
Agreement and Plan of Merger, dated as of March 17, 2004, as amended on April
16, 2004 (the "Merger Agreement"), by and among Fisher, Fox Merger
Corporation, a direct, wholly-owned subsidiary of Fisher ("Merger Sub"), and
Apogent Technologies Inc. ("Apogent"). Pursuant to the Merger Agreement,
Merger Sub was merged with and into Apogent (the "Merger") and Apogent, as the
surviving corporation, became a direct, wholly-owned subsidiary of Fisher,
effective at 11:00 a.m., Central Time, on August 2, 2004.

         In the Merger, each then outstanding share of Apogent common stock
was automatically converted into and became the right to receive 0.56 (the
"Exchange Ratio") shares of Fisher common stock, plus cash in lieu of
fractional shares. In addition, Fisher assumed each then outstanding option to
purchase Apogent common stock, with the number of shares and per share
exercise price appropriately adjusted to reflect the Exchange Ratio.

         Pursuant to the Merger Agreement, upon consummation of the Merger,
the board of directors of Fisher was expanded to include four members
designated by Apogent. The Apogent directors elected to the Fisher board of
directors are Frank H. Jellinek, Jr., Richard W. Vieser, Christopher L. Doerr,
and Simon B. Rich, who were all serving as directors of Apogent immediately
prior to the effective time of the Merger. Frank H. Jellinek, Jr. has also
been appointed to serve as the Chairman Emeritus of Fisher.

         Attached hereto as Exhibit 99.1 is Fisher's press release dated
August 2, 2004 announcing the completion of the merger with Apogent.

         Fisher anticipates that it will file a Form 8-K/A which will include
the financial statements and the pro forma financial statements giving effect
to the transaction required by Item 2 and Item 7 no later than 60 days from
the date this report on Form 8-K was required to be filed.




                                   SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                         Fisher Scientific International Inc.


Date: August 18, 2004                    By:  /s/ Todd M. DuChene
                                              -------------------------------
                                              Name:  Todd M. DuChene
                                              Title: Vice President, General
                                                     Counsel and Secretary




                                 Exhibit Index



Exhibit Number                     Description
--------------          ------------------------------------------------------
Exhibit 99.1            Fisher Scientific International Inc.'s press release
                        dated August 2, 2004 announcing the completion
                        of the merger with Apogent Technologies Inc.